AR023151A1 - PHARMACEUTICAL PREPARATION CONTAINING AS AN ACTIVE PRINCIPLE, AT LEAST ONE PART OF ACETILSALICILIC ACID - Google Patents

PHARMACEUTICAL PREPARATION CONTAINING AS AN ACTIVE PRINCIPLE, AT LEAST ONE PART OF ACETILSALICILIC ACID

Info

Publication number
AR023151A1
AR023151A1 ARP000101318A ARP000101318A AR023151A1 AR 023151 A1 AR023151 A1 AR 023151A1 AR P000101318 A ARP000101318 A AR P000101318A AR P000101318 A ARP000101318 A AR P000101318A AR 023151 A1 AR023151 A1 AR 023151A1
Authority
AR
Argentina
Prior art keywords
preparation containing
pharmaceutical preparation
active principle
acid
acetilsalicilic
Prior art date
Application number
ARP000101318A
Other languages
Spanish (es)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of AR023151A1 publication Critical patent/AR023151A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums

Abstract

Un preparado médico que contiene como principio activo por lo menos una parte de ácido acetilsalicílico para alcanzar, en la sangre de un organismo, elnivel de plasma necesario para combatir los estados de dolor y/o fiebre o para prevenir la trombosis, que se caracteriza por el hecho de que se presenta enforma de administracion transmucosal para la aplicacion bucal de Aspirina.A medical preparation containing as active ingredient at least a part of acetylsalicylic acid to reach, in the blood of an organism, the level of plasma necessary to combat the states of pain and / or fever or to prevent thrombosis, which is characterized by the fact that it is presented as a transmucosal administration for the oral application of Aspirin.

ARP000101318A 1999-03-26 2000-03-24 PHARMACEUTICAL PREPARATION CONTAINING AS AN ACTIVE PRINCIPLE, AT LEAST ONE PART OF ACETILSALICILIC ACID AR023151A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19913731A DE19913731A1 (en) 1999-03-26 1999-03-26 Medicinal preparation containing at least a portion of acetylsalicylic acid as active ingredient

Publications (1)

Publication Number Publication Date
AR023151A1 true AR023151A1 (en) 2002-09-04

Family

ID=7902490

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000101318A AR023151A1 (en) 1999-03-26 2000-03-24 PHARMACEUTICAL PREPARATION CONTAINING AS AN ACTIVE PRINCIPLE, AT LEAST ONE PART OF ACETILSALICILIC ACID

Country Status (4)

Country Link
AR (1) AR023151A1 (en)
AU (1) AU3430600A (en)
DE (1) DE19913731A1 (en)
WO (1) WO2000057884A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10338544B4 (en) * 2003-08-19 2017-08-31 Janssen Pharmaceutica N.V. Buccal formulations of galanthamine and their applications

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485920A (en) * 1967-06-12 1969-12-23 Gen Foods Corp Analgesic compositions of aspirin and pectin
DE2501548A1 (en) * 1974-01-25 1975-07-31 Procter & Gamble ORAL TREATMENT PRODUCTS
JPH07553B2 (en) * 1985-12-09 1995-01-11 佐藤製薬株式会社 Film preparation
DE3935550A1 (en) * 1989-10-25 1991-05-02 Pharmatrans Sanaq Ag Chewable or suckable medicine, process for its manufacture and its use
DE4102629A1 (en) * 1991-01-30 1992-08-06 Bayer Ag PHARMACEUTICAL RUBBER WITH ACETYL SALICYLIC ACID
JPH10508018A (en) * 1994-10-28 1998-08-04 ザ、プロクター、エンド、ギャンブル、カンパニー Denture stabilizing composition

Also Published As

Publication number Publication date
DE19913731A1 (en) 2000-09-28
WO2000057884A1 (en) 2000-10-05
AU3430600A (en) 2000-10-16

Similar Documents

Publication Publication Date Title
MXPA02012792A (en) Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates.
UY26977A1 (en) IMIDAZOL COMPOUNDS CONDENSED WITH ARILO OR HETEROARILO AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS
ATE401892T1 (en) USE OF PHARMACEUTICAL PREPARATIONS CONTAINING OXCARBAZEPINE IN THE FUTTING STATE
PT1207756E (en) USE OF ESPINOSADE OR A FORMULATION THAT INCLUDES ESPINOSADE
AR240250A1 (en) PROCEDURE FOR THE PREPARATION OF A NEW ORAL PHARMACEUTICAL FORMULATION CONTAINING OMEPRAZOLE AS AN ACTIVE INGREDIENT.
ECSP034883A (en) AMIDAS OF ANTRANILIC ACIDS WITH SIDE CHAIN OF HETEROARILSULFONILO, PROCEDURE FOR THEIR PREPARATION, ITS EMPLOYMENT AS A MEDICINAL OR DIAGNOSTIC AGENT, AS WELL AS PHARMACEUTICAL PREPARATIONS CONTAINING THEM
ATE353009T1 (en) PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH SOFT GELATIN FORMULATIONS
UY25192A1 (en) DRUG FORMULATION WITH CONTROLLED RELEASE OF ACTIVE SUBSTANCE
AR048318A1 (en) ORAL MATRIX FORMULATIONS THAT INCLUDE LICARBAZEPINA
PT1383752E (en) 3-PIPERIDINOPROPYOPHENONES DETERMINED AS WELL AS PHARMACONS CONTAINING THESE COMPOUNDS
BR0014826A (en) Bicyclic imidazo-3-yl-amines, their preparation procedure and medications containing them
ES2119748T3 (en) PHARMACEUTICAL COMPOSITION CONTAINING A PHARMACEUTICALLY SOLUBLE IN WATER.
ES2139842T3 (en) USE OF MELATONIN TO TREAT PATIENTS WHO SUFFER DRUG DEPENDENCE.
AR023151A1 (en) PHARMACEUTICAL PREPARATION CONTAINING AS AN ACTIVE PRINCIPLE, AT LEAST ONE PART OF ACETILSALICILIC ACID
CA2474430A1 (en) A combination of a thrombolytic agent and levosimendan for the treatment of acute myocardial infarction
PT1202956E (en) THERAPEUTIC AND / OR NURITIONALLY IMPROVED DERIVATIVES OF ACTIVE INGREDIENTS AND ORAL ADMINISTRATION COMPOSITIONS CONTAINING THE SAME
ES2182504T3 (en) BIFENILSULFONILCIANAMIDAS, PROCEDURE FOR ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT.
AR048138A1 (en) PHARMACEUTICAL FORMULATION OF CONTROLLED LIBERATION
PT1242062E (en) GEL ANIDRO UNDERSTANDING NSAID FOR TOPIC ADMINISTRATION IN ORAL CAVITY
AR029096A1 (en) COMBINATION OF ACTIVE SUBSTANCES CONTAINING MONTIRELINE AND A COMPOUND OF OPIOID EFFECT, MEDICATIONS AND MEDICINAL FORMULATIONS CONTAINING SUCH COMBINATION AND ITS USE FOR THE PREPARATION OF MEDICATIONS FOR PAIN TREATMENT
DE50005282D1 (en) MEDICINE AND MATCHED COMBINATION OF MEDICINES
HN1999000174A (en) ACUISA MEDICATION FORMULATION FOR ORAL ADMINISTRATION.
ATE494239T1 (en) DEVICE FOR DISPENSING PHARMACEUTICAL PRODUCTS
CU23150A3 (en) MEDICINAL FORMULATION WITH CONTROLLED RELEASE OF ACTIVE SUBSTANCE
ATE257377T1 (en) BLISTER CONTAINING A TRANSDERMAL THERAPEUTIC SYSTEM AND A SINGLE DOSE PHARMACEUTICAL FORM